Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02606461
Title KCP-330-020 SEAL (Selinexor in Advanced Liposarcoma) (SEAL)
Acronym SEAL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | SWE | ITA | ISR | GBR | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.